Amarantus Bioscience Holdings Inc (AMBS)

[MagicCap]

A close above $0.069 will be a new closing high since October. We have bumped up against this 4 times now and formed a cup and handle. The breakout projects to 0.11 initially.

I always look at closing prices instead of the intraday noise.

Again, $14 Million market cap for a company with patent protection on a drug that has had much better results than GDNF which was owned by a company bought out for $250 Million and a drug that the co-founder of Amgen said could be a blockbuster makes me think there is much more upside than 0.11. That would only be a market cap of around $25 million.

The jan 8th conference could provide a massive spark. Major exposure there especially with the Amgen founder presenting on MANF's commercial potential outside of PD. I think we come away with a partnership and licensing deal (with an upfront payment and milestone payments) within a month after that.